How big is the North America Hemodynamic Monitoring Market?

The North America Hemodynamic Monitoring Market size is expected to reach USD 539.72 million in 2024 and grow at a CAGR of 3.17% to reach USD 630.87 million by 2029. Read More

What is the current North America Hemodynamic Monitoring Market size?

In 2024, the North America Hemodynamic Monitoring Market size is expected to reach USD 539.72 million. Read More

Who are the key players in North America Hemodynamic Monitoring Market?

Koninklijke Philips NV, Getinge Group, Edwards Lifesciences Corporation, GE Healthcare and ICU Medical Inc are the major companies operating in the North America Hemodynamic Monitoring Market. Read More

What years does this North America Hemodynamic Monitoring Market cover, and what was the market size in 2023?

In 2023, the North America Hemodynamic Monitoring Market size was estimated at USD 523.14 million. The report covers the North America Hemodynamic Monitoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Hemodynamic Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Hemodynamic Monitoring Market Share

Statistics for the 2023 & 2024 North America Hemodynamic Monitoring market share, created by Mordor Intelligence™ Industry Reports. North America Hemodynamic Monitoring share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of North America Hemodynamic Monitoring Industry

The North American hemodynamic monitoring market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of companies, including Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, and GE Healthcare.